Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 4/20 | 0.67 |
| ▸ | CHRNB4 | P30926 | 4/20 | 0.67 |
| ▸ | CHRNA3 | P32297 | 4/20 | 0.67 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.67 |
| ▸ | HDAC7 | Q8WUI4 | 3/20 | 0.64 |
| ▸ | BCAT2 | O15382 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | HTT | P42858 | 2/20 | 0.57 |
| ▸ | GAA | P10253 | 2/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | MPO | P05164 | 1/20 | 0.55 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.55 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.54 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.54 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8089215 | 0.96 | CHRNB2 (0.62) | CHRNB2CHRNB4CHRNA3CHRNA4HDAC7 | |
| SCHEMBL27460658 | 0.94 | HDAC7 (0.67) | CHRNB2CHRNB4CHRNA3CHRNA4HDAC7 | |
| SCHEMBL12922045 | 0.92 | HDAC7 (0.60) | CHRNB2CHRNB4CHRNA3CHRNA4HDAC7 | |
| SCHEMBL12922053 | 0.87 | HDAC8 (0.59) | CHRNB2CHRNB4CHRNA3CHRNA4HDAC7 | |
| SCHEMBL3026631 | 0.87 | GAA (0.64) | CHRNB2CHRNB4CHRNA3CHRNA4HDAC7 | |
| SCHEMBL974404 | 0.85 | SLC6A3 (0.63) | CHRNB2CHRNB4CHRNA3CHRNA4HDAC7 | |
| SCHEMBL14880211 | 0.85 | HNF4A (0.68) | CHRNB2CHRNB4CHRNA3CHRNA4HDAC7 | |
| SCHEMBL13845096 | 0.85 | HDAC7 (0.66) | CHRNB2CHRNB4CHRNA3CHRNA4HDAC7 | |
| SCHEMBL29256186 | 0.83 | HDAC7 (0.59) | CHRNB2CHRNB4CHRNA3CHRNA4HDAC7 | |
| SCHEMBL27471401 | 0.83 | HDAC7 (0.51) | CHRNB2CHRNB4CHRNA3CHRNA4HDAC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250275536-A1 | Antimicrobial Composition | KAMER, Patrick (CH) | 2025-09-04 | — | — | US | claimed |
| EP-4518653-A1 | ANTIMICROBIAL COMPOSITION | Kamer, Patrick (CH) | 2025-03-12 | — | — | EP | claimed |
| WO-2023213846-A1 | ANTIMICROBIAL COMPOSITION | KAMER PATRICK (CH) | 2023-11-09 | — | — | WO | claimed |
| US-20110021771-A1 | INHIBITORS OF HISTONE DEACETYLASE | METHYLGENE INC. (CA) | 2011-01-27 | — | — | US | claimed |
| EP-2217588-A1 | INHIBITORS OF HISTONE DEACETYLASE | Methylgene, Inc. (CA) | 2010-08-18 | — | — | EP | claimed |
| WO-2009055917-A1 | INHIBITORS OF HISTONE DEACETYLASE | METHYLGENE INC. (CA) | 2009-05-07 | — | — | WO | claimed |
| US-20250275536-A1 | Antimicrobial Composition | KAMER, Patrick (CH) | 2025-09-04 | — | — | US | disclosed |
| EP-4518653-A1 | ANTIMICROBIAL COMPOSITION | Kamer, Patrick (CH) | 2025-03-12 | — | — | EP | disclosed |
| US-20240109847-A1 | HISTONE DEACETYLASE INHIBITORS | THE UNIVERSITY OF QUEENSLAND (AU) | 2024-04-04 | — | — | US | disclosed |
| WO-2023213846-A1 | ANTIMICROBIAL COMPOSITION | KAMER PATRICK (CH) | 2023-11-09 | — | — | WO | disclosed |
| EP-3239143-B1 | BIARYL DERIVATIVE AS GPR120 AGONIST | LG CHEMICAL LTD (KR) | 2023-03-22 | — | — | EP | disclosed |
| WO-2022133551-A1 | HISTONE DEACETYLASE INHIBITORS | THE UNIVERSITY OF QUEENSLAND (AU) | 2022-06-30 | — | — | WO | disclosed |
| CN-107410317-A | Improve the diffusible wet tissue composition in wet tissue fabric and the wet tissue containing said composition | 明进新科技股份有限公司 | 2017-12-01 | — | — | CN | disclosed |
| WO-2000056300-A2 | SYNTHESIS AND STRUCTURE OF METALLOCENE COMPOUNDS AND THEIR INTERACTIONS WITH LIPID MEMBRANES | PARKER HUGHES INSTITUTE (US) | 2000-09-28 | — | — | WO | disclosed |
| EP-0874808-A1 | BIPHENYL HYDROXAMATE INHIBITORS OF MATRIX METALLOPROTEINASES | Abbott Laboratories (US) | 1998-11-04 | — | — | EP | disclosed |
| WO-1998008904-A1 | ELECTRODEPOSITABLE COATING COMPOSITIONS CONTAINING HYDROXAMIC ACID AND DERIVATIVES THEREOF, AND THEIR USE IN A METHOD OF ELECTRODEPOSITION | PPG INDUSTRIES, INC. (US) | 1998-03-05 | — | — | WO | disclosed |
| US-5665777-A | ANTIINFLAMMATORY AGENTS | ABBOTT LABORATORIES (US) | 1997-09-09 | — | — | US | disclosed |
| WO-1997018188-A1 | BIPHENYL HYDROXAMATE INHIBITORS OF MATRIX METALLOPROTEINASES | ABBOTT LABORATORIES (US) | 1997-05-22 | — | — | WO | disclosed |
| US-4009116-A | Process of preparing substantially organic waste liquids containing radioactive or toxic substances for safe, non-pollutive handling, transportation and permanent storage | BAYER AKTIENGESELLSCHAFT (DT) | 1977-02-22 | — | — | US | disclosed |
| US-3960762-A | Production of absorbents | BAYER AKTIENGESELLSCHAFT (DT) | 1976-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110021771-A1 | INHIBITORS OF HISTONE DEACETYLASE | HDAC1, HDAC11, HDAC3 | CHRNB2 2327/4885CHRNB4 2355/4885CHRNA3 1459/4885 |
| US-20250275536-A1 | Antimicrobial Composition | CUTA, POLR1C, PIK3C3 | CHRNB2 4802/4885CHRNB4 4790/4885CHRNA3 4736/4885 |
| US-20240109847-A1 | HISTONE DEACETYLASE INHIBITORS | HDAC1, HDAC3, HDAC11 | CHRNB2 2882/4885CHRNB4 3749/4885CHRNA3 1961/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.